申请人:Roussel Uclaf
公开号:US04278677A1
公开(公告)日:1981-07-14
Novel tetrahydropyridinyl indoles of the formula ##STR1## wherein R' is selected from the group consisting of hydrogen, halogen and alkoxy of 1 to 3 carbon atoms, R.sub.1 and R.sub.2 are individually selected from the group consisting of hydrogen and alkyl of 1 to 3 carbon atoms and X' is selected from the group consisting of alkyl of 1 to 6 carbon atoms, cycloalkyl of 4 to 7 carbon atoms, alkenyl and alkynyl of 2 to 5 carbon atoms and aralkyl of 7 to 12 carbon atoms with the proviso that when X' is methyl, at least one of R', R.sub.1 and R.sub.2 contain more than one carbon atom and when X' is benzyl, at least one of R', R.sub.1 and R.sub.2 must not be hydrogen and their non-toxic, pharmaceutically acceptable acid addition salts having antidepressive and neuroleptic properties as well as antiemetic properties.
新颖的四氢吡啶基吲哚化合物的化学式为##STR1##其中R'从氢、卤素和1至3个碳原子的烷氧基中选择,R.sub.1和R.sub.2分别从氢和1至3个碳原子的烷基中选择,X'从1至6个碳原子的烷基、4至7个碳原子的环烷基、2至5个碳原子的烯基和炔基以及7至12个碳原子的芳基中选择,但当X'为甲基时,至少其中一个R'、R.sub.1和R.sub.2含有多于一个碳原子,当X'为苄基时,至少其中一个R'、R.sub.1和R.sub.2不能是氢,并且它们的无毒、药理学上可接受的酸盐具有抗抑郁和抗精神分裂作用以及止吐作用。